Next generation of polymeric nanovaccine for brain cancer immunotherapy

This WINS fellowship aims to study a new gene-based strategy for cancer immunotherapy developing an in situ cancer nanovaccine that will stimulate danger sensors in glioblastoma cells leading to immunogenic cancer cell death